SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-011986
Filing Date
2020-05-13
Accepted
2020-05-13 16:03:31
Documents
89
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_immucellcorp.htm 10-Q 517377
2 CERTIFICATION f10q0320ex31_immucellcorp.htm EX-31 9331
3 CERTIFICATION f10q0320ex32_immucellcorp.htm EX-32 4776
  Complete submission text file 0001213900-20-011986.txt   4261876

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20200331.xml EX-101.INS 701026
5 XBRL SCHEMA FILE iccc-20200331.xsd EX-101.SCH 57808
6 XBRL CALCULATION FILE iccc-20200331_cal.xml EX-101.CAL 64252
7 XBRL DEFINITION FILE iccc-20200331_def.xml EX-101.DEF 173764
8 XBRL LABEL FILE iccc-20200331_lab.xml EX-101.LAB 418546
9 XBRL PRESENTATION FILE iccc-20200331_pre.xml EX-101.PRE 321138
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 20873151
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences